reported that the m6a modification can promote the progression of pancreatic ductal adenocarcinoma, which involves the expression of m6a-related mRNAs such as METTL14, IGFBP2, and ALKBH5 (28–30). This evidence concerns the gene IGFBP2 and pancreatic ductal adenocarcinoma.